Paper36920188
In Vitro and In Vivo Efficacy of NITD-916 against Mycobacterium fortuitum.
Roquet-Banères F and 5 others. Antimicrob Agents Chemother, 2023. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. In Vitro and In Vivo Efficacy of NITD-916 against Mycobacterium fortuitum. Papers, record 36920188. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36920188
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mycobacterium fortuitum | Major topic |
| Mycobacterium tuberculosis | Major topic |
| Animals | |
| Zebrafish | |
| Mycolic Acids | |
| Oxidoreductases |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| HHSN272201700059C | NIAID NIH HHS | United States | PubMed |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34392175 | Mycobacterium enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discovery. | Bioorg Chem | 2021 | https://conductscience.org/library/papers/34392175 | PubMed |
| 2 | 32417538 | Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors. | Eur J Med Chem | 2020 | https://conductscience.org/library/papers/32417538 | PubMed |
| 3 | 17555433 | The Mycobacterium tuberculosis FAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development. | Mol Microbiol | 2007 | https://conductscience.org/library/papers/17555433 | PubMed |
| 4 | 24374164 | Mycolic acids: structures, biosynthesis, and beyond. | Chem Biol | 2014 | https://conductscience.org/library/papers/24374164 | PubMed |
| 5 | 30429139 | Cutaneous Mycobacterial Infections. | Clin Microbiol Rev | 2018 | https://conductscience.org/library/papers/30429139 | PubMed |
| 6 | 9328647 | The envelope layers of mycobacteria with reference to their pathogenicity. | Adv Microb Physiol | 1998 | https://conductscience.org/library/papers/9328647 | PubMed |
| 7 | 28084211 | Rapidly Growing Mycobacteria. | Microbiol Spectr | 2017 | https://conductscience.org/library/papers/28084211 | PubMed |
| 8 | 28807917 | Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28807917 | PubMed |
| 9 | 31860799 | Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in Mycobacterium abscessus. | ACS Infect Dis | 2020 | https://conductscience.org/library/papers/31860799 | PubMed |
| 10 | 30687747 | In Vitro Susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum Isolates to 30 Antibiotics. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/30687747 | PubMed |
| 11 | 26104214 | The Molecular Genetics of Mycolic Acid Biosynthesis. | Microbiol Spectr | 2014 | https://conductscience.org/library/papers/26104214 | PubMed |
| 12 | 26382225 | Deciphering and Imaging Pathogenesis and Cording of Mycobacterium abscessus in Zebrafish Embryos. | J Vis Exp | 2015 | https://conductscience.org/library/papers/26382225 | PubMed |
| 13 | 17220416 | EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17220416 | PubMed |
| 14 | 32906655 | Mycobacteriosis and Infections with Non-tuberculous Mycobacteria in Aquatic Organisms: A Review. | Microorganisms | 2020 | https://conductscience.org/library/papers/32906655 | PubMed |
| 15 | 33920196 | Gene Sequencing and Phylogenetic Analysis: Powerful Tools for an Improved Diagnosis of Fish Mycobacteriosis Caused by Mycobacterium fortuitum Group Members. | Microorganisms | 2021 | https://conductscience.org/library/papers/33920196 | PubMed |
| 16 | 37619220 | Druggable redox pathways against Mycobacterium abscessus in cystic fibrosis patient-derived airway organoids. | PLoS Pathog | 2023 | https://conductscience.org/library/papers/37619220 | PubMed |
| 17 | 31768399 | The Integrated Resource for Reproducibility in Macromolecular Crystallography: Experiences of the first four years. | Struct Dyn | 2019 | https://conductscience.org/library/papers/31768399 | PubMed |
| 18 | 25568071 | Direct inhibitors of InhA are active against Mycobacterium tuberculosis. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/25568071 | PubMed |
| 19 | 10716087 | Mycobacterium fortuitum osteomyelitis in a peripheral blood stem cell transplant recipient. | Scand J Infect Dis | 2000 | https://conductscience.org/library/papers/10716087 | PubMed |
| 20 | 8284673 | inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. | Science | 1994 | https://conductscience.org/library/papers/8284673 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41683947 | Phagocytosis of Mycobacterium fortuitum by Caprine Alveolar Macrophages Is Associated with iNOS and Pro-Inflammatory Markers Expression. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683947 | PubMed |
| 41142442 | Advancements in laboratory diagnostics for HIV/MTB coinfection: Integrating conventional methods with emerging technologies. | Pract Lab Med | 2025 | https://conductscience.org/library/papers/41142442 | PubMed |
| 40635565 | An alveolus lung-on-a-chip model of Mycobacterium fortuitum lung infection. | Dis Model Mech | 2025 | https://conductscience.org/library/papers/40635565 | PubMed |
| 39329871 | Tuberculosis Diagnosis: Current, Ongoing, and Future Approaches. | Diseases | 2024 | https://conductscience.org/library/papers/39329871 | PubMed |
| 37314394 | New therapeutic strategies for Mycobacterium abscessus pulmonary diseases - untapping the mycolic acid pathway. | Expert Rev Anti Infect Ther | 2023 | https://conductscience.org/library/papers/37314394 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36920188
GET https://conductscience.org/api/papers/v1/36920188/references?page=2